Impact of microvascular alterations in heart failure. Effect of cardiac transplantation and ACE inhibition.
Galatius
S
S
Department of Medicine, Hillerød Hospital, University of Copenhagen.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002199:Capillary Permeability / Q000502:physiology*; D019332:Endothelin-1 / Q000378:metabolism*; D004727:Endothelium / Q000378:metabolism; D005260:Female; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy; D016027:Heart Transplantation; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D011187:Posture / Q000502:physiology; D012039:Regional Blood Flow; D014841:von Willebrand Factor / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D019332:Endothelin-1; D014841:von Willebrand Factor